Professor Stephanie Amiel, Honorary Consultant in Diabetes at King’s College Hospital in London, has received a Damehood for services to people living with diabetes.
As an experimental medicine researcher and a clinical diabetes physician, in her career she has used multiple methods to investigate clinical problems in diabetes therapies, including hypoglycaemia in insulin therapy, the role of the brain in the control of peripheral metabolism, and the impact of black African ethnicity on the metabolic derangements that lead to Type 2 diabetes.
Dame Amiel works collaboratively with colleagues in neuroimaging, nutrition, psychology and education and transplantation to improve outcomes particularly for adults with Type 1 diabetes. With Sheffield and North Tyneside, and nursing colleagues from King’s College Hospital, she led the King’s team in the development of the patient education programme DAFNE and continues to work on improvements to the original curriculum. With the King’s Liver teams, she also developed islet transplantation at King’s for adults with Type 1 diabetes and treatment-resistant hypoglycaemia.
Amiel is a founder member of the International Hypoglycaemia Study Group, which first set out the now widely adopted definitions of hypoglycaemia in diabetes; participated in the development of international guidelines for the use of metabolic surgery in Type 2 diabetes and the use of continuous glucose monitoring in improving diabetes outcomes. She has chaired the NICE guideline development group for the most recent clinical guideline in the diagnosis and management of Type 1 diabetes in adults. She is also chairman of the Strategic Research Advisory Group for Diabetes UK and part of the EU IMI initiative HypoRESOLVE, which seeks to define hypoglycaemia in terms of its impact on patients’ lives. She is also a mentor on the European Federation for the Study of Diabetes (EFSD) research mentorship programme and sits on its panel.
Her current research is funded by Breakthrough Type 1 UK, Diabetes UK and other organisations in Europe.